GenMark Diagnostics (GenMark Diagnostics) Days Sales Outstanding : 33.73 (As of Dec. 2020)

View and export this data going back to 2010. Start your Free Trial

What is GenMark Diagnostics Days Sales Outstanding?

GenMark Diagnostics's average Accounts Receivable for the three months ended in Dec. 2020 was $18.5 Mil. GenMark Diagnostics's Revenue for the three months ended in Dec. 2020 was $50.1 Mil. Hence, GenMark Diagnostics's Days Sales Outstanding for the three months ended in Dec. 2020 was 33.73.

The historical rank and industry rank for GenMark Diagnostics's Days Sales Outstanding or its related term are showing as below:

GNMK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.23 Med: 55.82 Max: 68.54
Current: 41.43

During the past 13 years, GenMark Diagnostics's highest Days Sales Outstanding was 68.54. The lowest was 38.23. And the median was 55.82.

GNMK's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 63.94 vs GNMK: 41.43

GenMark Diagnostics's Days Sales Outstanding declined from Dec. 2019 (45.64) to Dec. 2020 (33.73).

GenMark Diagnostics Days Sales Outstanding Historical Data

The historical data trend for GenMark Diagnostics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GenMark Diagnostics Days Sales Outstanding Chart

GenMark Diagnostics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Days Sales Outstanding

Get a 7-Day Free Trial

58.87

68.54

57.28

58.66

39.94

GenMark Diagnostics Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Days Sales Outstanding	Get a 7-Day Free Trial															45.64	50.03	49.61	36.48	33.73

Competitive Comparison of GenMark Diagnostics's Days Sales Outstanding

For the Medical Devices subindustry, GenMark Diagnostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GenMark Diagnostics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GenMark Diagnostics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where GenMark Diagnostics's Days Sales Outstanding falls into.

GenMark Diagnostics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

GenMark Diagnostics's Days Sales Outstanding for the fiscal year that ended in Dec. 2020 is calculated as

	Days Sales Outstanding (A: Dec. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2019 )	+	Accounts Receivable (A: Dec. 2020 ))	/	count )	/	Revenue (A: Dec. 2020 )	*	Days in Period
=	( (16.759	+	20.79)	/	2 )	/	171.554	*	365
=	18.7745					/	171.554	*	365
=	39.94

GenMark Diagnostics's Days Sales Outstanding for the quarter that ended in Dec. 2020 is calculated as:

	Days Sales Outstanding (Q: Dec. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2020 )	+	Accounts Receivable (A: Dec. 2020 ))	/	count )	/	Revenue (A: Dec. 2020 )	*	Days in Period
=	( (16.231	+	20.79)	/	2 )	/	50.08	*	365 / 4
=	18.5105					/	50.08	*	365 / 4
=	33.73

GenMark Diagnostics (NAS:GNMK) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

GenMark Diagnostics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of GenMark Diagnostics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

GenMark Diagnostics (GenMark Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GenMark Diagnostics Inc (NAS:GNMK) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

5964 La Place Court, Carlsbad, CA, USA, 92008-8829

Website

http://www.genmarkdx.com

GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its operations and assets are in the United States of America.

Executives

Tyler Jensen	officer: SVP, Engineering and Tech Dev	5964 LA PLACE COURT CARLSBAD CA 92008
Christine Shaw	officer: VP, Assay Development	5964 LA PLACE COURT CARLSBAD CA 92008
Alan Baer Maderazo	officer: VP, Qual, Reg, & Clin Affairs	5964 LA PLACE COURT CARLSBAD CA 92008
Michael Gleeson	officer: SVP, Corp. Accounts	5964 LA PLACE COURT, SUITE 100 CARLSBAD CA 92008
Sarah Hollis Winkler	officer: VP, Human Resources	5964 LA PLACE COURT CARLSBAD CA 92008
Michael John Harkins	officer: SVP, Sales	5964 LA PLACE COURT CARLSBAD CA 92008
John Frederick Ek	officer: Chief Financial Officer	5964 LA PLACE COURT, CARLSBAD CA 92008
Scott Mendel	director, officer: President & CEO	5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Eric Stier	officer: SVP & General Counsel	5964 LA PLACE COURT CARLSBAD CA 92008
Brian Andrew Mitchell	officer: SVP, Operations	5964 LA PLACE COURT CARLSBAD CA 92008
Daryl Faulkner	director	5964 LA PLACE COURT, CARLSBAD CA 92008
Michael Kagnoff	director	DLA PIPER LLP (US) 4365 EXECUTIVE DRIVE, SUITE 1100 SAN DIEGO CA 92121
Lisa M. Giles	director	DURATA THERAPEUTICS, INC., 200 SOUTH WACKER DRIVE SUITE 2550, CHICAGO IL 60606
Kevin C Oboyle	director	5964 LA PLACE COURT, CARLSBAD CA 92008
James Fox	director	5964 LA PLACE COURT, CARLSBAD CA 92008